Literature DB >> 14645931

Transfection of prion protein gene suppresses coxsackievirus B3 replication in prion protein gene-deficient cells.

Yuko Nakamura1, Akikazu Sakudo1, Keiichi Saeki1, Tomomi Kaneko1, Yoshitsugu Matsumoto1, Antonio Toniolo2, Shigeyoshi Itohara3, Takashi Onodera1.   

Abstract

The susceptibility of prion protein gene (Prnp)-null cells to coxsackievirus B3 (CVB3) was investigated. Primary cultures of murine Prnp(-/-) brain cells were more sensitive to CVBs than corresponding cells from wild-type mice. The viral susceptibility of a Prnp-null cell line (HpL3-4) derived from the murine hippocampus was compared with that of two established cell lines (HeLa and HEp-2) that are widely employed for CVB3 studies. After infection with CVB3, HpL3-4 cells showed a very rapid and complete cytopathic effect (CPE). CPE developed earlier and viruses replicated at higher titres in HpL3-4 cells compared with HeLa and HEp-2 cells. Under a semi-solid medium, plaques developed rapidly in CVB3-infected HpL3-4 cells. To confirm the effect of Prnp on virus infection, a Prnp(-/-) cell line and a Prnp-transfected neuronal cell line were analysed. The replication and release of infectious particles of CVB3 in Prnp(-/-) cells were significantly more effective than those of the Prnp-transfected cell line. Levels of type I interferon (IFN) after CVB3 infection were higher in the Prnp-transfected cell line than in Prnp(-/-) cells, whereas apoptotic cells were more obvious in the Prnp(-/-) cells than in those of the Prnp-transfected cell line. These findings suggest that the absence of Prnp retards the induction of CVB3-induced IFNs, resulting in an enhanced CVB3 production and apoptotic cell death. Furthermore, our data indicate that the HpL3-4 cell line may provide a novel and sensitive system for isolation of CVB3 from clinical specimens.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14645931     DOI: 10.1099/vir.0.19222-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  8 in total

1.  Functional mechanisms of the cellular prion protein (PrP(C)) associated anti-HIV-1 properties.

Authors:  Sandrine Alais; Ricardo Soto-Rifo; Vincent Balter; Henri Gruffat; Evelyne Manet; Laurent Schaeffer; Jean Luc Darlix; Andrea Cimarelli; Graça Raposo; Théophile Ohlmann; Pascal Leblanc
Journal:  Cell Mol Life Sci       Date:  2011-11-11       Impact factor: 9.261

2.  Poliovirus type 1 infection of murine PRNP-knockout neuronal cells.

Authors:  Andreina Baj; Alessia Bettaccini; Takuya Nishimura; Takashi Onodera; Antonio Toniolo
Journal:  J Neurovirol       Date:  2005-07       Impact factor: 2.643

Review 3.  Cellular prion protein neuroprotective function: implications in prion diseases.

Authors:  Xavier Roucou; Andréa C LeBlanc
Journal:  J Mol Med (Berl)       Date:  2004-11-10       Impact factor: 4.599

4.  A proautophagic antiviral role for the cellular prion protein identified by infection with a herpes simplex virus 1 ICP34.5 mutant.

Authors:  Maria Korom; Kristine M Wylie; Hong Wang; Katie L Davis; Meher S Sangabathula; Gregory S Delassus; Lynda A Morrison
Journal:  J Virol       Date:  2013-03-13       Impact factor: 5.103

5.  Hepatitis C virus-induced prion protein expression facilitates hepatitis C virus replication.

Authors:  Huixia Zhang; Shanshan Gao; Rongjuan Pei; Xinwen Chen; Chaoyang Li
Journal:  Virol Sin       Date:  2017-10-25       Impact factor: 4.327

Review 6.  Prion protein (PrP) gene-knockout cell lines: insight into functions of the PrP.

Authors:  Akikazu Sakudo; Takashi Onodera
Journal:  Front Cell Dev Biol       Date:  2015-01-15

7.  Prion protein lacks robust cytoprotective activity in cultured cells.

Authors:  Heather M Christensen; David A Harris
Journal:  Mol Neurodegener       Date:  2008-08-21       Impact factor: 14.195

8.  Prion Protein PRNP: A New Player in Innate Immunity? The Aβ Connection.

Authors:  Richard Lathe; Jean-Luc Darlix
Journal:  J Alzheimers Dis Rep       Date:  2017-12-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.